In the News
- Nanoscope Therapeutics announces first patient dosed in STARLIGHT Phase 2 clinical trial of MCO-010 optogenetic gene therapy for Stargardt disease
- Nanoscope Therapeutics announces 3 new appointments to its scientific and clinical advisory board
- ARVO sets stage for virtual event
- CRISPR used to restore retinal function
- Retinitis pigmentosa may be treated by reprogramming sugar metabolism